Morningstar Highlights Promising Biotech Stocks Amid Sector Rebound Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal Microsoft Appoints New Responsible Tech Lead to Humanize Rapid AI Development Russias New Law Grants Central Bank Authority to Deploy AntiDrone Systems Amid Rising Attacks Gift Nifty Signals Strong Start for Indian Equities as Global Sentiment Improves Over Weekend HS2 Costs Balloon to 1027bn as UK Government Grapples with SunkCost Fallacy OCUL Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage BNR Q3 2022 Earnings Narrower Loss Surprises Wall Street as Stock Drops 11 on Broader Biotech Selloff Diageo Q1 2026 Earnings EPS Misses Estimates Amidst Mixed Market Sentiment Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting Sanmina Q1 2026 Earnings Strong EPS Surge Defies Estimates MOB Q4 2025 Earnings Significant EPS Miss Despite Strong Stock Rally LZ Technology Holdings LZMH Edges Lower as Stock Tests Key Support Near 114 BristolMyers Squibb BMY Declines 218 Support Levels in Focus as Stock Holds Above 55 Novanta Inc NOVT Rebounds Sharply Testing Key Resistance Zone Tempus AI TEM Slightly Lower as Shares Consolidate Near Support Levels Rezolve AI RZLV Declines 209 Approaching Critical Support at 245 Bandus Blockbusters Engages Investors with Weekly Stock Picking Challenge AEHR Q1 2026 Earnings Narrowerthanexpected loss drives positive stock reaction Inspire Medical Systems INSP Holds Steady Near 42 as Support and Resistance Define a Tight Trading Range Singapores AI Investment Boom Brings Geopolitical Risks Warns MTI HighYield Savings Account Rates Top 41 APY as of May 23 2026 Hong Kong Gold Clearing System Could Bolster Hub Status by July Salesforce Shares Decline on Soft Revenue Outlook Amid Persistent AI Disruption Concerns UK Startup BioOrbit Launches Drug Manufacturing to Space with SpaceX Targeting SelfInjected Cancer Therapies Quiet Luxury 2026s Top Silent SUVs Signal Shift in Auto Industry JP Morgan Lowers Price Target on Banco Bilbao Vizcaya Argentaria BBVA but Retains Overweight Rating